Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer

Auteurs

Javier Cortés, Véronique Diéras, Sylvie Lorenzen, Filippo Montemurro, Jorge Riera-Knorrenschild, Peter Thuss-Patience, Giacomo Allegrini, Michelino De Laurentiis, Caroline Lohrisch, Eva Oravcová, Jose M. Perez-Garcia, Francesco Ricci, Dina Sakaeva, Rosanne Serpanchy, Jozef Šufliarský, Maria Vidal, Natsumi Irahara, Christine Wohlfarth, Mounir Aout, Karen Gelmon